Global Molecular Diagnostics Market – Market Forecast, Market Trend, Market Research and Opportunity, Size and Share – 2014-2027

Overview

Global molecular diagnostics market is expected to grow with a CAGR of 10.0% from 2017 to 2027

Molecular diagnostic tests identify particular sequences in DNA or RNA (counting single nucleotide polymorphism (SNP), deletions, insertions, rearrangements and others) that could be or not related with any ailment.

Molecular diagnostics will reduce healthcare costs for patients by maintaining a strategic distance from chemotherapy, medicinal care, and medications. It can likewise be utilized to recognize cancer biomarkers, which will enhance the survival rate of patients. The capacity of Molecular diagnostics to approve cancer biomarkers and enhance persistent care will prompt the development of this market amid the anticipated period.

High prevalence of infectious diseases and different types of cancer; expanding awareness and acceptance of companion diagnostics and personalized drug; growth in biomarkers; and progress in molecular procedures, proteomics, and genomics innovation research and transformations in the reimbursement framework are driving the development of the market. Although, increase in cost of molecular diagnostics device, lack of skilled labor to deal with new and complex stages, and the complex administrative structure are the main considerations limiting the development of the market.

The global molecular diagnostics market, by products and services, is divided into reagents and kits, instruments, and software & services. The reagents and kits market is anticipated to grow at the most leading CAGR of the market during the analysis period. Development in the reagents and kits section is driven by headway, for example, advancement in automation and development of high-throughput technologies in instruments.

The global molecular diagnostics market, by application, is divided into infectious diseases, oncology, blood screening, genetic tests, microbiology, and other applications (cardiovascular diseases, DNA fingerprinting, neurological diseases, tissue typing, and food pathogen detection testing). The infectious diseases section represents the highest share of the worldwide market in 2016. This huge share is credited to the advancement and developments of cutting edge new tests for various ailments and conditions, uncommon events of contaminations, and increasing awareness about the utilization of molecular diagnostics advancement in technologies and products to control ailments.

The global molecular diagnostics market, by technology is divided into PCR, isothermal nucleic acid amplification technology (INAAT), hybridization (In-Situ Hybridization & Fish) , DNA sequencing and next-generation sequencing, microarrays and other technologies (electrophoresis, mass spectrometry and flow cytometry). Among these technologies, PCR generated the highest share and microarray is required to be the most noteworthy developing section. The extensive share of this section is fundamentally credited to the developing utilization of PCR in proteomics and genomics, automation of PCR instruments, and rise of cutting edge advancements like qRT-PCR.

The global molecular diagnostics market, by end user is divided into hospital & academic laboratories, reference laboratories, and other end users (blood banks, home health agencies, local public health laboratories,   point-of-care settings, nursing homes, and self-testing). As most diagnostic tests are performed in-house, the hospital & academic laboratories section is expected to lead the market. Then again, recently launched, complex, and very specific tests are offered just at a couple of large reference laboratories and research centers. Henceforth, the fragment will develop at the quickest pace.

The global molecular diagnostics market, by region, North America (comprising the U.S. Canada, and Mexico) is held the highest share of the global molecular diagnostic market in 2016, followed by Europe. The highest share of the North American market is significantly determined by the rising predominance of infectious diseases, government funds, and extension of the uses and application of molecular diagnostics in genetic disorder and cancer screening. The Asia-Pacific region is anticipated to develop at the most noteworthy CAGR during the analysis period. The development in this regional section can fundamentally be ascribed to the existence of developing markets, for example, China, India, and Australia.

Market Dynamics

Drivers

  • High prevalence of cancer
  • Rising incidences of infectious disorders
  • Increase in awareness and acceptance of personalized medicines
  • Advancements in molecular techniques, proteomics, and genomics technology research
  • Development of biomarkers

Restrains

  • Stringent regulatory requirements for the approval of new molecular diagnostics techniques
  • High cost of molecular diagnostics tools
  • Death of skilled labor to handle new and complex platform

Report Key Benefits

datos-market-post-rd1

Table of Content

  1. Market Introduction
    • Market Definition
    • Market Scope
    • Market Segments
    • Key Market Players
    • Report Key Benefits
  2. Research Methodology
    • Research Process
    • Market Estimations and Trend Analysis
    • Executive Summary
  3. Market Dynamics
    • Market Share Analysis
    • Porter’s Five Forces
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  4. Global Molecular Diagnostics Market by Product & Services
    • Market Overview, by Product & Services
    • Reagents & Kits
      • Overview
      • Market Share, 2016
      • Market Size and Forecast
    • Instruments
      • Overview
      • Market Share, 2016
      • Market Size, 2014-2027
    • Software & Services
      • Overview
      • Market Share, 2016
      • Market Size, 2014-2027
  1. Global Molecular Diagnostics Market by Application
    • Market Overview, by Application
    • Infectious Diseases
      • Overview
      • Market Share, 2016
      • Market Size, 2014-2027
      • Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
        • Overview
        • Market Share, 2016
        • Market Size, 2014-2027
      • Hepatitis B
        • Overview
        • Market Share, 2016
        • Market Size, 2014-2027
      • Human Papillomavirus (HPV)
        • Overview
        • Market Share, 2016
        • Market Size, 2014-2027
      • Human Immunodeficiency Virus (HIV)
        • Overview
        • Market Share, 2016
        • Market Size, 2014-2027
      • Tuberculosis (TB)
        • Overview
        • Market Share, 2016
        • Market Size, 2014-2027
      • Hepatitis C

 

  • Overview
  • Market Share, 2016
  • Market Size, 2014-2027
  • Methicillin-Resistant Staphylococcus Aureus (MRSA)
    • Overview
    • Market Share, 2016
    • Market Size, 2014-2027
  • Other Infectious Diseases
    • Overview
    • Market Share, 2016
    • Market Size, 2014-2027
  • Oncology
    • Overview
    • Market Share, 2016
    • Market Size, 2014-2027
    • Breast Cancer
      • Overview
      • Market Share, 2016
      • Market Size, 2014-2027
    • Colorectal Cancer
      • Overview
      • Market Share, 2016
      • Market Size, 2014-2027
    • Prostate Cancer
      • Overview
      • Market Share, 2016
      • Market Size, 2014-2027
    • Other Cancers
      • Overview
      • Market Share, 2016
      • Market Size, 2014-2027
  • Blood Screening
    • Overview
    • Market Share, 2016
    • Market Size, 2014-2027
  • Genetic Tests
    • Overview
    • Market Share, 2016
    • Market Size, 2014-2027
  • Microbiology
    • Overview
    • Market Share, 2016
    • Market Size, 2014-2027
  • Other Applications
    • Overview
    • Market Share, 2016
    • Market Size, 2014-2027

 

  1.  Global Molecular Diagnostics Market by Technology
    • Market Overview, by Technology
    • Polymerase Chain Reaction (PCR)
      • Overview
      • Market Share, 2016
      • Market Size, 2014-2027
    • Isothermal Nucleic Acid Amplification Technology (INAAT)
      • Overview
      • Market Share, 2016
      • Market Size, 2014-2027
    • Hybridization (In-Situ Hybridization & Fish)
      • Overview
      • Market Share, 2016
      • Market Size, 2014-2027
    • DNA Sequencing and Next-Generation Sequencing
      • Overview
      • Market Share, 2016
      • Market Size, 2014-2027
    • Microarray
      • Overview
      • Market Share, 2016
      • Market Size, 2014-2027
    • Other Technologies
      • Overview
      • Market Share, 2016
      • Market Size, 2014-2027

 

  1. Global Molecular Diagnostics Market by End Users
    • Market Overview, by End Users
    • Hospital and Academic Laboratories

 

  • Overview
  • Market Share, 2016
  • Market Size, 2014-2027
  • Reference Laboratories
    • Overview
    • Market Share, 2016
    • Market Size, 2014-2027
  • Other End Users
    • Overview
    • Market Share, 2016
    • Market Size, 2014-2027
  1. Global Molecular Diagnostics Market by Geography
    • Market Overview by Geography
    • North America
      • Overview
      • Market Share, 2016
      • Market Size, 2014-2027
      • U.S.
        • Overview
        • Market Share, 2016
        • Market Size, 2014-2027
      • Canada
        • Overview
        • Market Share, 2016
        • Market Size, 2014-2027
      • Mexico
        • Overview
        • Market Share, 2016
        • Market Size , 2014-2027
      • Europe
        • Overview
        • Market Share, 2016
        • Market Size, 2014-2027
        • Germany
          • Overview
          • Market Share, 2016
          • Market Size, 2014-2027
        • United Kingdom
          • Overview
          • Market Share, 2016
          • Market Size, 2014-2027
        • France
          • Overview
          • Market Share, 2016
          • Market Size, 2014-2027
        • Spain
          • Overview
          • Market Share, 2016
          • Market Size, 2014-2027
        • Italy
          • Overview
          • Market Share, 2016
          • Market Size, 2014-2027
        • Rest of Europe
          • Overview
          • Market Share, 2016
          • Market Size, 2014-2027

 

  • Asia-Pacific
    • Overview
    • Market Share, 2016
    • Market Size, 2014-2027
    • Japan
      • Overview
      • Market Share, 2016
      • Market Size, 2014-2027
    • China
      • Overview
      • Market Share, 2016
      • Market Size, 2014-2027
    • India
      • Overview
      • Market Share, 2016
      • Market Size, 2014-2027
    • Australia
      • Overview
      • Market Share, 2016
      • Market Size, 2014-2027
    • South Korea
      • Overview
      • Market Share, 2016
      • Market Size, 2014-2027
    • Rest of Asia-Pacific
      • Overview
      • Market Share, 2016
      • Market Size, 2014-2027

 

  • Rest Of World
    • Overview
    • Market Share, 2016
    • Market Size, 2014-2027
    • Brazil
      • Overview
      • Market Share, 2016
      • Market Size, 2014-2027
    • Argentina
      • Overview
      • Market Share, 2016
      • Market Size, 2014-2027
    • South Africa
      • Overview
      • Market Share, 2016
      • Market Size, 2014-2027
    • Middle East
      • Overview
      • Market Share, 2016
      • Market Size, 2014-2027
    • Others
      • Overview
      • Market Share, 2016
      • Market Size, 2014-2027
  1. Company profiles
    • Abbott Laboratories

 

  • Overview
  • Financials
  • Business Segments
  • Recent Developments
  • Qiagen N.V.
    • Overview
    • Financials
    • Business Segments
    • Recent Developments
  • Roche Diagnostics
    • Overview
    • Financials
    • Business Segments
    • Recent Developments
  • Hologic, Inc.
    • Overview
    • Financials
    • Business Segments
    • Recent Developments
  • Grifols
    • Overview
    • Financials
    • Business Segments
    • Recent Developments
  • Siemens Healthcare
    • Overview
    • Financials
    • Business Segments
    • Recent Developments
  • Becton, Dickinson and Company
    • Overview
    • Financials
    • Business Segments
    • Recent Developments
  • Beckman Coulter Inc.
    • Overview
    • Financials
    • Business Segments
    • Recent Developments
  • Biomérieux Sa
    • Overview
    • Financials
    • Business Segments
    • Recent Developments
  • Cepheid Inc.
    • Overview
    • Financials
    • Business Segments
    • Recent Developments

List of Tables

Table 1:  Global Molecular Diagnostics Market, by Products & Services, 2014-2027, (Million USD)

Table 2:  Global Molecular Diagnostics Market, for Reagents & Kits, by Geography, 2014-2027, (Million USD)

Table 3:  Global Molecular Diagnostics Market, for Instruments, by Geography, 2014-2027, (Million USD)

Table 4:  Global Molecular Diagnostics Market, for Software & Services, by Geography, 2014-2027, (Million USD)

Table 5:  Global Molecular Diagnostics Market, by Application, 2014-2027, (Million USD)

Table 6:  Global Molecular Diagnostics Market, for Infectious Diseases , by Type, 2014-2027, (Million USD)

Table 7:  Global Molecular Diagnostics Market, for Infectious Diseases , by Geography, 2014-2027, (Million USD)

Table 8:  Global Molecular Diagnostics Market, for Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG), by Geography, 2014-2027, (Million USD)

Table 9:  Global Molecular Diagnostics Market, for Hepatitis B, by Geography, 2014-2027, (Million USD)

Table 10:  Global Molecular Diagnostics Market, for Human Papillomavirus (HPV), by Geography, 2014-2027, (Million USD)

Table 11:  Global Molecular Diagnostics Market, for Human Immunodeficiency Virus (HIV), by Geography, 2014-2027, (Million USD)

Table 12:  Global Molecular Diagnostics Market, for Tuberculosis (TB), by Geography, 2014-2027, (Million USD)

Table 13:  Global Molecular Diagnostics Market, for Hepatitis C, by Geography, 2014-2027, (Million USD)

Table 14:  Global Molecular Diagnostics Market, for Methicillin-Resistant Staphylococcus Aureus (MRSA), by Geography, 2014-2027, (Million USD)

Table 15:  Global Molecular Diagnostics Market, for Other Infectious Diseases, by Geography, 2014-2027, (Million USD)

Table 16:  Global Molecular Diagnostics Market, for Oncology, by Type, 2014-2027, (Million USD)

Table 17:  Global Molecular Diagnostics Market, for Oncology, by Geography, 2014-2027, (Million USD)

Table 18:  Global Molecular Diagnostics Market, for Breast Cancer, by Geography, 2014-2027, (Million USD)

Table 19:  Global Molecular Diagnostics Market, for Colorectal Cancer, by Geography, 2014-2027, (Million USD)

Table 20:  Global Molecular Diagnostics Market, for Prostate Cancer, by Geography, 2014-2027, (Million USD)

Table 21:  Global Molecular Diagnostics Market, for Other Cancers, by Geography, 2014-2027, (Million USD)

Table 22:  Global Molecular Diagnostics Market, for Blood Screening , by Geography, 2014-2027, (Million USD)

Table 23:  Global Molecular Diagnostics Market, for Genetic Tests , by Geography, 2014-2027, (Million USD)

Table 24:  Global Molecular Diagnostics Market, for Microbiology , by Geography, 2014-2027, (Million USD)

Table 25:  Global Molecular Diagnostics Market, for Other Applications, by Geography, 2014-2027, (Million USD)

Table 26:  Global Molecular Diagnostics Market, by Technology, 2014-2027, (Million USD)

Table 27:  Global Molecular Diagnostics Market, for Polymerase Chain Reaction (PCR) , by Geography, 2014-2027, (Million USD)

Table 28:  Global Molecular Diagnostics Market, for Isothermal Nucleic Acid Amplification Technology (INAAT) , by Geography, 2014-2027, (Million USD)

Table 29:  Global Molecular Diagnostics Market, for Hybridization (In-Situ Hybridization & Fish) , by Geography, 2014-2027, (Million USD)

Table 30:  Global Molecular Diagnostics Market, for DNA Sequencing and Next-Generation Sequencing , by Geography, 2014-2027, (Million USD)

Table 31:  Global Molecular Diagnostics Market, for Microarray , by Geography, 2014-2027, (Million USD)

Table 32:  Global Molecular Diagnostics Market, for Other Technologies , by Geography, 2014-2027, (Million USD)

Table 33:  Global Molecular Diagnostics Market, by End User, by Type, 2014-2027, (Million USD)

Table 34:  Global Molecular Diagnostics Market, for Hospital and Academic Laboratories , by Geography, 2014-2027, (Million USD)

Table 35:  Global Molecular Diagnostics Market, for Reference Laboratories , by Geography, 2014-2027, (Million USD)

Table 36:  Global Molecular Diagnostics Market, for Other End Users, by Geography, 2014-2027, (Million USD)

Table 37:  North America Molecular Diagnostics Market, by Country, 2014-2027, (Million USD)

Table 38:  North America Molecular Diagnostics Market, by Products & Services, 2014-2027, (Million USD)

Table 39:  North America Molecular Diagnostics Market, by Application, 2014-2027, (Million USD)

Table 40:  North America Molecular Diagnostics Market, by Technology, 2014-2027, (Million USD)

Table 41:  North America Molecular Diagnostics Market, by End User, 2014-2027, (Million USD)

Table 42:  U.S. Molecular Diagnostics Market, by Products & Services, 2014-2027, (Million USD)

Table 43:  U.S. Molecular Diagnostics Market, by Application, 2014-2027, (Million USD)

Table 44:  U.S. Molecular Diagnostics Market, by Technology, 2014-2027, (Million USD)

Table 45:  U.S. Molecular Diagnostics Market, by End User, 2014-2027, (Million USD)

Table 46:  Canada Molecular Diagnostics Market, by Products & Services, 2014-2027, (Million USD)

Table 47:  Canada Molecular Diagnostics Market, by Application, 2014-2027, (Million USD)

Table 48:  Canada Molecular Diagnostics Market, by Technology, 2014-2027, (Million USD)

Table 49:  Canada Molecular Diagnostics Market, by End User, 2014-2027, (Million USD)

Table 50:  Mexico Molecular Diagnostics Market, by Products & Services, 2014-2027, (Million USD)

Table 51:  Mexico Molecular Diagnostics Market, by Application, 2014-2027, (Million USD)

Table 52:  Mexico Molecular Diagnostics Market, by Technology, 2014-2027, (Million USD)

Table 53:  Mexico Molecular Diagnostics Market, by End User, 2014-2027, (Million USD)

Table 55:  Europe Molecular Diagnostics Market, by Country, 2014-2027, (Million USD)

Table 56:  Europe Molecular Diagnostics Market, by Products & Services, 2014-2027, (Million USD)

Table 57:  Europe Molecular Diagnostics Market, by Application, 2014-2027, (Million USD)

Table 58:  Europe Molecular Diagnostics Market, by Technology, 2014-2027, (Million USD)

Table 59:  Europe Molecular Diagnostics Market, by End User, 2014-2027, (Million USD)

Table 60:  Germany Molecular Diagnostics Market, by Products & Services, 2014-2027, (Million USD)

Table 61:  Germany Molecular Diagnostics Market, by Application, 2014-2027, (Million USD)

Table 62:  Germany Molecular Diagnostics Market, by Technology, 2014-2027, (Million USD)

Table 63:  Germany Molecular Diagnostics Market, by End User, 2014-2027, (Million USD)

Table 64:  UK Molecular Diagnostics Market, by Products & Services, 2014-2027, (Million USD)

Table 65:  UK Molecular Diagnostics Market, by Application, 2014-2027, (Million USD)

Table 66:  UK Molecular Diagnostics Market, by Technology, 2014-2027, (Million USD)

Table 67:  UK Molecular Diagnostics Market, by End User, 2014-2027, (Million USD)

Table 68:  France Molecular Diagnostics Market, by Products & Services, 2014-2027, (Million USD)

Table 69:  France Molecular Diagnostics Market, by Application, 2014-2027, (Million USD)

Table 70:  France Molecular Diagnostics Market, by Technology, 2014-2027, (Million USD)

Table 71:  France Molecular Diagnostics Market, by End User, 2014-2027, (Million USD)

Table 72:  Spain Molecular Diagnostics Market, by Products & Services, 2014-2027, (Million USD)

Table 73:  Spain Molecular Diagnostics Market, by Application, 2014-2027, (Million USD)

Table 74:  Spain Molecular Diagnostics Market, by Technology, 2014-2027, (Million USD)

Table 75:  Spain Molecular Diagnostics Market, by End User, 2014-2027, (Million USD)

Table 76:  Italy Molecular Diagnostics Market, by Products & Services, 2014-2027, (Million USD)

Table 77:  Italy Molecular Diagnostics Market, by Application, 2014-2027, (Million USD)

Table 78:  Italy Molecular Diagnostics Market, by Technology, 2014-2027, (Million USD)

Table 79:  Italy Molecular Diagnostics Market, by End User, 2014-2027, (Million USD)

Table 80:  Rest of Europe Molecular Diagnostics Market, by Products & Services, 2014-2027, (Million USD)

Table 81:  Rest of Europe Molecular Diagnostics Market, by Application, 2014-2027, (Million USD)

Table 82:  Rest of Europe Molecular Diagnostics Market, by Technology, 2014-2027, (Million USD)

Table 83:  Rest of Europe Molecular Diagnostics Market, by End User, 2014-2027, (Million USD)

Table 84:  Asia-Pacific Molecular Diagnostics Market, by Country, 2014-2027, (Million USD)

Table 85:  Asia-Pacific Molecular Diagnostics Market, by Products & Services, 2014-2027, (Million USD)

Table 86:  Asia-Pacific Molecular Diagnostics Market, by Application, 2014-2027, (Million USD)

Table 87:  Asia-Pacific Molecular Diagnostics Market, by Technology, 2014-2027, (Million USD)

Table 88:  Asia-Pacific Molecular Diagnostics Market, by End User, 2014-2027, (Million USD)

Table 89:  Japan Molecular Diagnostics Market, by Products & Services, 2014-2027, (Million USD)

Table 90:  Japan Molecular Diagnostics Market, by Application, 2014-2027, (Million USD)

Table 91:  Japan Molecular Diagnostics Market, by Technology, 2014-2027, (Million USD)

Table 92:  Japan Molecular Diagnostics Market, by End User, 2014-2027, (Million USD)

Table 93:  China Molecular Diagnostics Market, by Products & Services, 2014-2027, (Million USD)

Table 94:  China Molecular Diagnostics Market, by Application, 2014-2027, (Million USD)

Table 95:  China Molecular Diagnostics Market, by Technology, 2014-2027, (Million USD)

Table 96:  China Molecular Diagnostics Market, by End User, 2014-2027, (Million USD)

Table 97:  India Molecular Diagnostics Market, by Products & Services, 2014-2027, (Million USD)

Table 98:  India Molecular Diagnostics Market, by Application, 2014-2027, (Million USD)

Table 99:  India Molecular Diagnostics Market, by Technology, 2014-2027, (Million USD)

Table 100:  India Molecular Diagnostics Market, by End User, 2014-2027, (Million USD)

Table 101:  Australia Molecular Diagnostics Market, by Products & Services, 2014-2027, (Million USD)

Table 102:  Australia Molecular Diagnostics Market, by Application, 2014-2027, (Million USD)

Table 103:  Australia Molecular Diagnostics Market, by Technology, 2014-2027, (Million USD)

Table 104:  Australia Molecular Diagnostics Market, by End User, 2014-2027, (Million USD)

Table 105:  South Korea Molecular Diagnostics Market, by Products & Services, 2014-2027, (Million USD)

Table 106:  South Korea Molecular Diagnostics Market, by Application, 2014-2027, (Million USD)

Table 107:  South Korea Molecular Diagnostics Market, by Technology, 2014-2027, (Million USD)

Table 108:  South Korea Molecular Diagnostics Market, by End User, 2014-2027, (Million USD)

Table 109:  Rest of Asia-Pacific Molecular Diagnostics Market, by Products & Services, 2014-2027, (Million USD)

Table 110:  Rest of Asia-Pacific Molecular Diagnostics Market, by Application, 2014-2027, (Million USD)

Table 111:  Rest of Asia-Pacific Molecular Diagnostics Market, by Technology, 2014-2027, (Million USD)

Table 112:  Rest of Asia-Pacific Molecular Diagnostics Market, by End User, 2014-2027, (Million USD)

Table 113:  Rest of World Molecular Diagnostics Market, by Country, 2014-2027, (Million USD)

Table 114:  Rest of World Molecular Diagnostics Market, by Products & Services, 2014-2027, (Million USD)

Table 115:  Rest of World Molecular Diagnostics Market, by Application, 2014-2027, (Million USD)

Table 116:  Rest of World Molecular Diagnostics Market, by Technology, 2014-2027, (Million USD)

Table 117:  Rest of World Molecular Diagnostics Market, by End User, 2014-2027, (Million USD)

Table 118:  Brazil Molecular Diagnostics Market, by Products & Services, 2014-2027, (Million USD)

Table 119:  Brazil Molecular Diagnostics Market, by Application, 2014-2027, (Million USD)

Table 120:  Brazil Molecular Diagnostics Market, by Technology, 2014-2027, (Million USD)

Table 121:  Brazil Molecular Diagnostics Market, by End User, 2014-2027, (Million USD)

Table 122:  Argentina Molecular Diagnostics Market, by Products & Services, 2014-2027, (Million USD)

Table 123:  Argentina Molecular Diagnostics Market, by Application, 2014-2027, (Million USD)

Table 124:  Argentina Molecular Diagnostics Market, by Technology, 2014-2027, (Million USD)

Table 125:  Argentina Molecular Diagnostics Market, by End User, 2014-2027, (Million USD)

Table 126:  South Africa Molecular Diagnostics Market, by Products & Services, 2014-2027, (Million USD)

Table 127:  South Africa Molecular Diagnostics Market, by Application, 2014-2027, (Million USD)

Table 128:  South Africa Molecular Diagnostics Market, by Technology, 2014-2027, (Million USD)

Table 129:  South Africa Molecular Diagnostics Market, by End User, 2014-2027, (Million USD)

Table 130:  Middle East Molecular Diagnostics Market, by Products & Services, 2014-2027, (Million USD)

Table 131:  Middle East Molecular Diagnostics Market, by Application, 2014-2027, (Million USD)

Table 132:  Middle East Molecular Diagnostics Market, by Technology, 2014-2027, (Million USD)

Table 133:  Middle East Molecular Diagnostics Market, by End User, 2014-2027, (Million USD)

Table 134:  Others Molecular Diagnostics Market, by Products & Services, 2014-2027, (Million USD)

Table 135:  Others Molecular Diagnostics Market, by Application, 2014-2027, (Million USD)

Table 136:  Others Molecular Diagnostics Market, by Technology, 2014-2027, (Million USD)

Table 137:  Others Molecular Diagnostics Market, by End User, 2014-2027, (Million USD)

Table 138:  Abbott Laboratories , Overview

Table 139:  Qiagen N.V. , Overview

Table 140:  Roche Diagnostics , Overview

Table 141:  Hologic, Inc. , Overview

Table 142:  Grifols , Overview

Table 143:  Siemens Healthcare , Overview

Table 144:  Becton, Dickinson and Company , Overview

Table 145:  Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) , Overview

Table 146:  Biomérieux Sa , Overview

Table 147:  Cepheid Inc., Overview

 

List of Figures

Figure 1.  Global Molecular Diagnostics Market Segments

Figure 2.  Global Molecular Diagnostics Market Share Analysis

Figure 3.  Global Molecular Diagnostics Market Share for Reagents & Kits, 2016, (%)

Figure 4.  Global Molecular Diagnostics Market Share for Instruments, 2016, (%)

Figure 5.  Global Molecular Diagnostics Market Share for Infectious Diseases, 2016, (%)

Figure 6.  Global Molecular Diagnostics Market Share for Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG), 2016, (%)

Figure 7.  Global Molecular Diagnostics Market Share for Hepatitis B, 2016, (%)

Figure 8.  Global Molecular Diagnostics Market Share for Human Papillomavirus (HPV), 2016, (%)

Figure 9.  Global Molecular Diagnostics Market Share for Human Immunodeficiency Virus (HIV), 2016, (%)

Figure 10.  Global Molecular Diagnostics Market Share for Tuberculosis (TB), 2016, (%)

Figure 11.  Global Molecular Diagnostics Market Share for Hepatitis C, 2016, (%)

Figure 12.  Global Molecular Diagnostics Market Share for Methicillin-Resistant Staphylococcus Aureus (MRSA), 2016, (%)

Figure 13.  Global Molecular Diagnostics Market Share for Other Infectious Diseases, 2016, (%)

Figure 14.  Global Molecular Diagnostics Market Share for Oncology, 2016, (%)

Figure 15.  Global Molecular Diagnostics Market Share for Breast Cancer, 2016, (%)

Figure 16.  Global Molecular Diagnostics Market Share for Colorectal Cancer, 2016, (%)

Figure 17.  Global Molecular Diagnostics Market Share for Prostate Cancer, 2016, (%)

Figure 18.  Global Molecular Diagnostics Market Share for Other Cancers, 2016, (%)

Figure 19.  Global Molecular Diagnostics Market Share for Blood Screening, 2016, (%)

Figure 20.  Global Molecular Diagnostics Market Share for Genetic Tests, 2016, (%)

Figure 21.  Global Molecular Diagnostics Market Share for Microbiology, 2016, (%)

Figure 22.  Global Molecular Diagnostics Market Share for Other Applications, 2016, (%)

Figure 23.  Global Molecular Diagnostics Market Share for Polymerase Chain Reaction (PCR), 2016, (%)

Figure 24.  Global Molecular Diagnostics Market Share for Isothermal Nucleic Acid Amplification Technology (INAAT) , 2016, (%)

Figure 25.  Global Molecular Diagnostics Market Share for Hybridization (In-Situ Hybridization & Fish), 2016, (%)

Figure 26.  Global Molecular Diagnostics Market Share for DNA Sequencing and Next-Generation Sequencing, 2016, (%)

Figure 27.  Global Molecular Diagnostics Market Share for Microarray, 2016, (%)

Figure 28.  Global Molecular Diagnostics Market Share for Other Technologies, 2016, (%)

Figure 29.  Global Molecular Diagnostics Market Share for Hospital and Academic Laboratories, 2016, (%)

Figure 30.  Global Molecular Diagnostics Market Share for Reference Laboratories, 2016, (%)

Figure 31.  Global Molecular Diagnostics Market Share for Other End Users, 2016, (%)

Figure 32.  North America Molecular Diagnostics Market Share, 2016, (%)

Figure 33.  North America Molecular Diagnostics Market by Country, 2014-2027, (Million USD)

Figure 34.  U.S. Molecular Diagnostics Market Share, 2016, (%)

Figure 35.  Canada Molecular Diagnostics Market Share, 2016, (%)

Figure 36.  Mexico Molecular Diagnostics Market Share, 2016, (%)

Figure 37.  Europe Molecular Diagnostics Market Share, 2016, (%)

Figure 38.  Europe Molecular Diagnostics Market by Country, 2014-2027, (Million USD)

Figure 39.  Germany Molecular Diagnostics Market Share, 2016, (%)

Figure 40.  UK Molecular Diagnostics Market Share, 2016, (%)

Figure 41.  France Molecular Diagnostics Market Share, 2016, (%)

Figure 42.  Spain Molecular Diagnostics Market Share, 2016, (%)

Figure 43.  Italy Molecular Diagnostics Market Share, 2016, (%)

Figure 44.  Rest of Europe Molecular Diagnostics Market Share, 2016, (%)

Figure 45.  Asia-Pacific Molecular Diagnostics Market Share, 2016, (%)

Figure 46.  Asia=Pacific Molecular Diagnostics Market by Country, 2014-2027, (Million USD)

Figure 47.  Japan Molecular Diagnostics Market Share, 2016, (%)

Figure 48.  China Molecular Diagnostics Market Share, 2016, (%)

Figure 49.  India Molecular Diagnostics Market Share, 2016, (%)

Figure 50.  Australia Molecular Diagnostics Market Share, 2016, (%)

Figure 51.  South Korea Molecular Diagnostics Market Share, 2016, (%)

Figure 52.  Rest of Asia-Pacific Molecular Diagnostics Market Share, 2016, (%)

Figure 53.  Rest of World Molecular Diagnostics Market Share, 2016, (%)

Figure 54.  Rest of World Molecular Diagnostics Market by Country, 2014-2027, (Million USD)

Figure 55.  Brazil Molecular Diagnostics Market Share, 2016, (%)

Figure 56.  Argentina Molecular Diagnostics Market Share, 2016, (%)

Figure 57.  South Africa Molecular Diagnostics Market Share, 2016, (%)

Figure 58.  Middle East Molecular Diagnostics Market Share, 2016, (%)

Figure 59.  Others Molecular Diagnostics Market Share, 2016, (%)

Market Segments

By Products & Services

  • Reagents & Kits
  • Instruments
  • Software & Services

 By Application

  • Infectious Diseases
    • Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
    • Hepatitis B
    • Human Papillomavirus (HPV)
    • Human Immunodeficiency Virus (HIV)
    • Tuberculosis (TB)
    • Hepatitis C
    • Methicillin-Resistant Staphylococcus Aureus (MRSA)
    • Other Infectious Diseases
  • Oncology
    • Breast Cancer
    • Colorectal Cancer
    • Prostate Cancer
    • Other Cancers
  • Blood Screening
  • Genetic Tests
  • Microbiology
  • Other Applications

By Technology

  • Polymerase Chain Reaction (PCR)
  • Isothermal Nucleic Acid Amplification Technology (INAAT)
  • Hybridization (In-Situ Hybridization & Fish)
  • DNA Sequencing and Next-Generation Sequencing
  • Microarray
  • Other Technologies

By End Users

  • Hospital and Academic Laboratories
  • Reference Laboratories
  • Other End Users

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Rest Of World
    • Brazil
    • Argentina
    • South Africa
    • Middle East
    • Rest of world

Company Profiles

  • Abbott Laboratories
  • Qiagen N.V.
  • Roche Diagnostics
  • Hologic, Inc.
  • Grifols
  • Siemens Healthcare
  • Becton, Dickinson and Company
  • Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation)
  • Biomérieux Sa
  • Cepheid Inc.

Target Audience

  • Manufacturers and distributors of molecular diagnostic instruments & assays
  • Hospital laboratories
  • Pharmaceutical and biotechnology companies
  • Research and consulting firms
  • Health insurance players
  • In vitro diagnostic (IVD) companies
  • Reference laboratories
Place an Order

Testimonial

Looking for a Market Analysis Report?